Business


Top Gainers of the Day: Gilead Sciences, Inc. (NASDAQ:GILD) from Biotechnology

Gilead Sciences Inc now has $89.25B valuation. Volume in the last session has decreased compared with UNP's average trading volume. About 4.94M shares traded. More interesting news about Gilead Sciences , Inc. The original version of this report can be viewed at https://www.thestockobserver.com/2017/06/21/gilead-sciences-inc-gild-stake-cut-by-first-bank-trust.html.


European Central Bank shifts view on rates: no new cuts needed

European Central Bank shifts view on rates: no new cuts needed

The ECB kept monetary policy unchanged on Thursday, with the main refinancing rate left unchanged at 0%, the rate on bank overnight deposits kept at -0.40%, while the rate on the marginal lending facility, or emergency overnight borrowing rate for banks, stayed at 0.25%.



Anthem, MDwise leaving Indiana health insurance exchange

Anthem will quit the Affordable Care Act's individual insurance markets in Wisconsin and its home state of in, the company said in a statement Wednesday. "When MDwise entered the Marketplace Exchange in 2014, it did so to provide continuity to its Medicaid members who no longer qualify for Medicaid and are looking to purchase coverage on the Marketplace Exchange".



Saudi king names son as crown prince to replace Nayef

Traditionally, the line of succession in Saudi Arabia has passed from brother to brother: King Salman came to the throne in 2015 after the death of his half-brother, Abdullah, and originally appointed his own half-brother, Muqrin bin Abdulaziz, as crown prince.



Elliot Daly leads charge of the midweek men

The Exeter wing seized on a doglegged Chiefs defensive line, to scythe home and seal the Lions' win. The Lions will play their first Test match for 12 years on New Zealand soil this weekend when they tackle the All Blacks at Eden Park .